Cyclic Guanosine Monophosphate and 10-Year Change in Left Ventricular Mass: the Multi-Ethnic Study of Atherosclerosis (MESA)

Cyclic guanosine monophosphate (cGMP) is a second messenger for natriuretic peptide (NP) and nitric oxide pathways; its enhancement a target for heart failure and cardiovascular disease (CVD). We evaluated whether plasma cGMP was associated with change in left ventricular mass (LVM) among individual...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomarkers
Autors principals: Subramanya, Vinita, Zhao, Di, Ouyang, Pamela, Ying, Wendy, Vaidya, Dhananjay, Ndumele, Chiadi E., Lima, Joao A., Guallar, Eliseo, Hoogeveen, Ron C., Shah, Sanjiv J., Heckbert, Susan R., Kass, David A., Post, Wendy S., Michos, Erin D.
Format: Artigo
Idioma:Inglês
Publicat: 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8281442/
https://ncbi.nlm.nih.gov/pubmed/33715578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/1354750X.2021.1893811
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars